SELLAS Life Sciences Group, Inc. (SLS) stock
SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.47−0.39 (-4.96%)
Close on Nov 16, 2026Market cap $1.51BP/E –Yield –
SELLAS Life Sciences cash
Cash and short-term investments held at the end of each period.
SELLAS Life Sciences's cash was $134.71M at Sep 30, 2026. For fiscal 2025 it was $71.79M, up 413.3% from the year before. Over ten years it grew 48.3% a year on average. The highest annual figure on record is $71.79M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $71.79M | +413.3% |
| FY2024 | Dec 31, 2024 | $13.99M | +431.8% |
| FY2023 | Dec 31, 2023 | $2.63M | -84.7% |
| FY2022 | Dec 31, 2022 | $17.23M | -19.7% |
| FY2021 | Dec 31, 2021 | $21.46M | -39.4% |
| FY2020 | Dec 31, 2020 | $35.40M | +379.9% |
| FY2019 | Dec 31, 2019 | $7.38M | +35.3% |
| FY2018 | Dec 31, 2018 | $5.45M | -57.2% |
| FY2017 | Dec 31, 2017 | $12.75M | +110.8% |
| FY2016 | Dec 31, 2016 | $6.05M | +332.9% |
| FY2015 | Dec 31, 2015 | $1.40M | -94.1% |
| FY2014 | Dec 31, 2014 | $23.65M | -50.5% |
| FY2013 | Dec 31, 2013 | $47.79M | +45.7% |
| FY2012 | Dec 31, 2012 | $32.81M | -31.3% |
| FY2011 | Dec 31, 2011 | $47.79M | +593.5% |
| FY2010 | Dec 31, 2010 | $6.89M | +21.2% |
| FY2009 | Dec 31, 2009 | $5.68M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $134.71M | +203.3% |
| Q2 FY2026 | Jun 30, 2026 | $138.34M | +444.7% |
| Q1 FY2026 | Mar 31, 2026 | $107.10M | +275.8% |
| Q4 FY2025 | Dec 31, 2025 | $71.79M | +413.3% |
| Q3 FY2025 | Sep 30, 2025 | $44.42M | +110.2% |
| Q2 FY2025 | Jun 30, 2025 | $25.40M | +174.7% |
| Q1 FY2025 | Mar 31, 2025 | $28.50M | +53.9% |
| Q4 FY2024 | Dec 31, 2024 | $13.99M | +431.8% |
| Q3 FY2024 | Sep 30, 2024 | $21.13M | +419.3% |
| Q2 FY2024 | Jun 30, 2024 | $9.25M | -33.5% |
| Q1 FY2024 | Mar 31, 2024 | $18.52M | -22.9% |
| Q4 FY2023 | Dec 31, 2023 | $2.63M | -84.7% |
| Q3 FY2023 | Sep 30, 2023 | $4.07M | -81.0% |
| Q2 FY2023 | Jun 30, 2023 | $13.91M | -48.7% |
| Q1 FY2023 | Mar 31, 2023 | $24.00M | +67.2% |
| Q4 FY2022 | Dec 31, 2022 | $17.23M | -19.7% |
| Q3 FY2022 | Sep 30, 2022 | $21.45M | -18.7% |
| Q2 FY2022 | Jun 30, 2022 | $27.09M | -9.8% |
| Q1 FY2022 | Mar 31, 2022 | $14.35M | -49.0% |
| Q4 FY2021 | Dec 31, 2021 | $21.46M | -39.4% |
| Q3 FY2021 | Sep 30, 2021 | $26.38M | +217.7% |
| Q2 FY2021 | Jun 30, 2021 | $30.02M | +772.6% |
| Q1 FY2021 | Mar 31, 2021 | $28.13M | +310.9% |
| Q4 FY2020 | Dec 31, 2020 | $35.40M | +379.9% |
| Q3 FY2020 | Sep 30, 2020 | $8.30M | -10.1% |
| Q2 FY2020 | Jun 30, 2020 | $3.44M | -73.3% |
| Q1 FY2020 | Mar 31, 2020 | $6.85M | +154.5% |
| Q4 FY2019 | Dec 31, 2019 | $7.38M | +35.3% |
| Q3 FY2019 | Sep 30, 2019 | $9.23M | -8.4% |
| Q2 FY2019 | Jun 30, 2019 | $12.87M | +28.7% |
| Q1 FY2019 | Mar 31, 2019 | $2.69M | -77.7% |
| Q4 FY2018 | Dec 31, 2018 | $5.45M | -57.2% |
| Q3 FY2018 | Sep 30, 2018 | $10.08M | +325.6% |
| Q2 FY2018 | Jun 30, 2018 | $10.00M | +109.8% |
| Q1 FY2018 | Mar 31, 2018 | $12.09M | +459.8% |
| Q4 FY2017 | Dec 31, 2017 | $12.75M | +110.8% |
| Q3 FY2017 | Sep 30, 2017 | $2.37M | – |
| Q2 FY2017 | Jun 30, 2017 | $4.77M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.16M | – |
| Q4 FY2016 | Dec 31, 2016 | $6.05M | – |
See a number that looks wrong?